Stephen Gunstream
President, CEO & DirectorMr. Stephen Gunstream serves as a Director at Alpha Teknova Inc. since September 2020 and as its President and Chief Executive Officer since May 2020. He served as Chief Business Officer of Alpha Teknova Inc. from December 2019 to May 2020. From June 2015 to December 2019, Mr. Gunstream served in multiple roles at Becton Dickinson & Co. (“BD”) (NYSE: BDX), a global medical technology company, most recently as Vice President and General Manager of BD Biosciences, where he was responsible for leading BD’s flow cytometry and genomics business. He served as Chief Commercial Officer at Integrated DNA Technologies, Inc. Mr. Gunstream has experience in the life sciences industry, with tenures including Vice President and General Manager for the research and clinical business at BD Biosciences and Chief Commercial Officer at Integrated DNA Technologies. From 2008 to 2015, Mr. Gunstream served in multiple roles at Integrated DNA Technologies, Incorporated. Prior to IDT, Mr. Gunstream held multiple product development and business development roles with Applied Biosystems Incorporated (now part of Thermo Fisher Scientific Inc.), a biomedical technology company, from 2001 to 2008. He is a named inventor on 11 issued patents and over 27 pending patents. Mr. Gunstream received a bachelor degree in Biomedical Engineering from Northwestern University and an MBA from the Fuqua School of Business at Duke University.
Positions
- Company NameAlpha Teknova, Inc.Stock CodeTKNOPositionPresident, CEO & DirectorColleagues
- PDPaul D. GrossmanChairman of the Board
- MCMatthew C. LowellChief Financial Officer
- DADamon A. TerrillGeneral Counsel, Chief Compliance Officer & Secretary
- JHJennifer HenrySenior Vice President of Marketing
- BMBrett M. RobertsonIndependent Director
- AVAlexander VosIndependent Director
- MJMartha J. DemskiIndependent Director
